FAQs about Health » Medications » Respiratory Drugs

News about Health » Medications » Respiratory Drugs

Sino Biopharmaceutical, GSK expand alliance with China rights to respiratory drugs - Reuters [Visit Site | Read More]

Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial - The Lancet [Visit Site | Read More]

Efficacy and safety of different inhaler types for asthma and chronic obstructive pulmonary disease. a systematic review and meta-analysis | npj Primary Care Respiratory Medicine - Nature [Visit Site | Read More]

European Biotechs Reshaping Respiratory Disease - PharmTech.com [Visit Site | Read More]

AZ pays $200m upfront for Sino Bio COPD drug - pharmaphorum [Visit Site | Read More]

Editorial: Drug development for respiratory infectious diseases and related complications in other systems - Frontiers [Visit Site | Read More]